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ABSTRACT
Apurinic/apyrimidinic endonuclease 1/redox
effector factor-1 (APE1/Ref-1, abbreviated as APE1)
is a molecule with dual functions in DNA repair and
redox regulation of transcription factors.
Accumulated work has shown that the biological
activities of APE1 are sensitive to oxidative stress;
however, whether APE1 functions can be regulated
by nitrosative stress remains unknown. In this
investigation, we found that S-nitrosoglutathion
(GSNO), a nitric oxide donor and also an
S-nitrosating agent, effectively stimulated nuclear
export of APE1 in a CRM1-independent manner. This
nuclear-cytoplasmic translocation was dependent
on S-nitrosation modification of APE1, as simulta-
neous mutation of S-nitrosation target sites Cys93
and Cys310 completely abrogated the cytoplasmic
redistribution. The translocation process was rever-
sal and specific, as it could be reversed by reductive
reagents, but could not be mimicked by H2O2.I n
structure, the region aa.64–80 and the beta-strand
aa.311–316 in proximity to Cys93 and Cys310 were
important for GSNO-induced APE1 relocalization.
In addition, a defect of importin-mediated nuclear
import pathway was found in the NO-insulted cells,
and p50 and HDAC2 were identified as APE1 nuclear
export inhibitory proteins. Together, this study may
provide a novel molecular mechanism, which links
nitrosative stress to APE1-associated physiological
and pathological processes.
INTRODUCTION
Human apurinic/apyrimidinic endonuclease 1/redox
eﬀector factor-1 (APE1/Ref-1) is a bifunctional
oxidative-stress-responsive protein (1–5). On one hand,
it acts as an apurinic/apyrimidinic endonuclease, during
the second step of the DNA base excision repair pathway,
which is responsible for the repair of cellular oxidative
DNA damages. On the other hand, it plays a crucial role,
as a coactivator for various transcription factors in
controlling gene expression by redox-dependent mechan-
ism. Therefore, the regulation of APE1 function is a very
important issue (5–7). The cellular function of APE1 is
coordinately controlled at several levels. Firstly, the
expression of APE1 can be upregulated by a variety of
reactive oxygen species (ROS) and ROS-generating
systems (6,8–10). Secondly, APE1 can be modiﬁed by
phosphorylation, acetylation, and redox modiﬁcation,
which are important for the regulation of its
DNA-binding, transcriptional regulation, and DNA
repair functions (3,11–14). Lastly, the APE1 subcellular
distribution varies according to diﬀerent cell types and
environment stresses. (1) The expression pattern of APE1
is mainly nuclear, but cytoplasmic staining has also been
reported (15–17). The latter is usually observed in highly
metabolically active or proliferative cells, which may
experience an increased oxidative stress (4,5).
(2) Generally, stimuli that induce APE1 expression are
also able to promote its intracellular movement. Various
redox-related stimuli can induce the translocation of
APE1 from cytoplasm to nucleus (9,18–20). The nuclear
import process may be dependent on an N-terminal
nuclear import sequence (NLS) that mediates the
importin-dependent nuclear import of APE1 (21).
(3) In B-lymphocyte, H2O2 stimulation can induce a
relocalization of APE1 into mitochondria (22). Recently,
a low abundance of mitochondrial-localized APE1 was
found as the N-terminal 33 residues-truncated form
(22,23). Although various subcellular localizations and
intracellular traﬃcking of APE1 have been reported,
little is known about how these phenomena are regulated.
Particularly, the mechanism of the redox regulated
localization change remains open.
Nitric oxide (NO) is a reactive free radical that plays a
central role in diverse signaling pathways (24–27). Apart
from the well-known cGMP-dependent signaling pathway
of NO, there is also a cGMP-independent pathway
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ubiquitous redox-related modiﬁcation of cysteine thiols by
nitric oxide, which transduces the bioactivity of NO.
S-nitrosation has been implicated in regulation of gene
transcription (28), enzyme activity (29), and protein
nuclear translocation (30). APE1 contains a redox-active
domain and three redox-sensitive cysteine residues, and
its subcellular localization seems redox-sensitive (4).
However, whether APE1 can be modiﬁed by NO-elicited
S-nitrosation and whether its subcellular distribution can
be regulated by this redox modiﬁcation have not been
reported.
In this study, we reported that APE1 can inducibly
translocate from nucleus to cytoplasm in response to nitric
oxide stimulation in a CRM1-independent manner. This
nuclear export process of APE1 isreversible anddependent
on the S-nitrosation of its Cys93 and Cys310 sites.
In structure, two antiparallel beta-strands close to Cys93
andCys310 were identiﬁed tobe required forNO-mediated
export of APE1. In addition, it was found that the
importin-mediated nuclear import pathway was repressed
in NO-insulted cells, which may prevent cytosolic APE1
from re-transporting into the nucleus. Thus, we for the
ﬁrst time reveal a molecular event that coordinates
S-nitrosation modiﬁcation and nuclear-cytosolic shuttling
of APE1. Since the disruption of APE1 subcellular
localization may result in a defect in intra-nuclear DNA
repair and transcriptional regulation functions, this ﬁnding
may establish a novel role of APE1 in NO-related
physiological and pathological processes.
MATERIALS AND METHODS
Reagents and plasmids
Leptomycin B (LMB), 1, 4-dithiothreitol (DTT), N-acetyl-
L-cysteine (NAC), cycloheximide (CHX) and other
reagents, which were not speciﬁed, were purchased
from Sigma. Methyl methanethionsulphonate (MMTS)
and N-[6-(biotinamido)hexyl]-3’-(2’-pyridyldithio) propio-
namide (Biotin-HPDP) were purchased from Pierce.
Hoechst 33342 was purchased from Molecular
Probes. PNRI-299 was a generous gift of Dr. Michael
Kahn (University of Washington, USA) (31).
S-Nitrosoglutathione (GSNO) was prepared as previously
described (32). The HA-APE1 expression plasmid was
kindly provided by Mark R. Kelley (Indiana University,
School of Medicine, USA) (33). The APE1 mutants
HA-APE1(C65S), HA-APE1(C93S), HA-APE1(C310S),
HA-APE1(C93/310S), and HA-APE1(C65/93/310S)
were generated by site-directed mutagenesis (Stratagene).
The expression vectors encoding APE1-truncated mutants
were generated by PCR ampliﬁcation of APE1 cDNA
fragments and subsequent cloning of the PCR products
into the XbaI and HindIII sites of pcDNA3.1-myc
expression vector (Invitrogen). The truncated mutants
were named based on the amino acid residues retained in
the constructs. For example, APE1 (43–318) contains
amino acids 43 to 318, while APE1(1–305) contains
amino acids 1 to 305. The APE1 (64-80) was created
by deleting amino acids 64–80 from the wild-type APE1.
GFP-IkB was kindly provided by Michael R.H. White
(University of Liverpool, UK) (34); EGFP-XRCC1 and
Flag-XRCC1 are kind gifts from Dr. Josiane Me ´ nissier-de
Murcia (Ecole Supe ´ rieure de Biotechnologie de
Strasbourg Boulevard S, France) (35); GFP-GFP-NLS
and GFP-GFP-M9 were kindly provided by Dr. Ralph H.
Kehlenbach (Universita ¨ t Heidelberg, Germany) (36);
CMV-p50, Flag-p53, HDAC2-Myc, and pcDNA4-Trx
were generous gifts from Dr. Warner C. Greene
(University of California, USA) (37), Dr. Kenji
Fukasawa (Yamaguchi University, Japan) (38),
Dr. Tony Kouzarides (Gurdon Institute and Department
of Pathology, UK) (39), and Dr. J. Haendeler (University
of Frankfurt, Germany) (40), respectively.
Cellculture andtransient transfection
Human HepG2 hepatoma cells and HEK293 embryonic
kidney cells (ATCC) were cultured in a DMEM medium
containing 10% fetal calf serum (FCS) at 378Ci naC O 2
incubator. Cell transfection was performed with JetPei
(Polyplus) transfection reagent according to the manu-
facturer’s instruction.
Immunofluorescence analysis
Indirect immunoﬂuorescence was performed as previously
described (41). In brief, HEK293 cells were transfected
with HA-APE1 or APE1-myc expression vector. 36h
later, cells were ﬁxed with 3.7% paraformaldehyde in PBS
for 30min, permeabilized with 0.2% Triton X-100 in PBS
for 10min, and then blocked with PBS containing
5% BSA and 10% FCS for 30min. The cells were
subsequently incubated with anti-HA antibody (Santa
Cruz, sc-805) or anti-myc antibody (Santa Cruz, sc-40)
overnight at 48C, and ﬂooded with Texas-Red-labeled
secondary antibody (Molecular Probe) for 60min. The cell
nuclei were stained with Hoechst 33342. The ﬂuorescence
image of the stained nuclei and the immunoﬂuorescence
image of HA-APE1 were observed on the laser-scanning
confocal microscope (Olympus FV500, Tokyo, Japan)
equipped with appropriate ﬁlters.
Cellfractionation
HepG2 cells growing on 35mm plates were harvested in
ice-cold PBS and pelleted by centrifugation at 2000g for
1min. Cell pellets were resuspended in ice-cold hypotonic
buﬀer (10mM HEPES (pH7.9), 10mM KCl, 0.1% Triton
X-100, and protease cocktail), vortexed for 15sec, and
incubated on ice for 15min followed by centrifugation at
1000g at 48C for 5min. The pellets were washed twice with
hypotonic buﬀer, and then resuspended in SDS sample
buﬀer (without dye or DTT) and boiled for 20min. After
a brief centrifugation, the supernatants were collected and
used as the nuclear fractions. Both cytosolic and nuclear
proteins were quantiﬁed by bicinchoninic acid protein
assay (Pierce) and subjected to Western blot analysis.
Biotin-switch assay
Cell lysates were prepared in lysis buﬀers (50mM
Tris (pH7.5), 150mM NaCl, 0.5% deoxycholic acid,
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cocktail). The supernatant of cell lysis was assayed for
protein concentration by BCA method, and then adjusted
to the appropriate concentration. Blocking buﬀer (2.5%
SDS, 20mM MMTS in HEN buﬀer) was mixed with the
samples and incubated for 30min at 508C to block free
thiol groups. After removing excess MMTS by acetone
precipitation, nitrosothiols were then reduced to thiols
and biotinylated by reducing buﬀer (1% SDS, 10mM
ascorbate, 4mM Biotin-HPDP). Then, the biotinylated
proteins were pulled down by streptavidin-agarose beads,
eluted by SDS sample buﬀer, and subjected to Western
blot analysis.
Westernblot analysis
Western blot analysis was performed according to
standard protocols. In brief, equal amount of protein
fractions or agarose beads were mixed with SDS sample
buﬀer, separated on 10% SDS–polyacrylamide gels, and
transferred to nitrocellulose membranes (Pall).
Then, rabbit anti-human APE1 polyclonal antibody
(Santa Cruz, sc-334), rabbit polyclonal HA antibody
(Santa Cruz, sc-805), mouse monoclonal tubulin
antibody (Santa Cruz sc-5286), and mouse monoclonal
Histone H1 antibody (Santa Cruz, sc-8030) were used as
primary antibodies to detect APE1, HA-APE1, tubulin,
and Histone H1, respectively. The horseradish-peroxidase-
conjugated secondary antibodies and enhanced chemi-
luminescence kit (Pierce) were used to visualize the
separated proteins.
RESULTS
GSNO-induced nuclear export ofAPE1 in a
CRM1-independent manner
To investigate whether nitric oxide was able to aﬀect the
subcellular distribution of APE1, HepG2 hepatoma cells
were treated with GSNO, a wildly used nitric oxide donor
and also an S-nitrosating agent (30,42). APE1 expressions
in both the cytoplasmic and nuclear fractions were
examined by immunoblotting analysis. As shown in
Figure 1A, GSNO stimulation resulted in a signiﬁcant
decrease of nuclear distribution of APE1 in a time-
dependent manner. At the same course, the cytosolic
APE1 contents were markedly enhanced. As a control,
H2O2 did not result in signiﬁcant change in nuclear or
cytosolic APE1 content (data not shown). These observa-
tions suggest a possibility that GSNO could stimulate
nuclear-to-cytoplasmic translocation of APE1 in HepG2
cells. To further conﬁrm this phenomenon, HA-APE1
expression vector was transiently transfected into
HEK293 cells together with GFP-fused XRCC1, another
DNA-repair-related protein (35), and the subcellular
distribution of APE1 was analyzed by immunoﬂuores-
cence with anti-HA antibody. As shown in Figure 1B, the
transfected APE1 was absolutely localized in the nucleus
in the untreated cells. However, treatment of cells with
1mM GSNO for 4h resulted in a clear translocation of
APE1 from the nucleus to the cytoplasm. In contrast, the
intra-nuclear localization of GFP-XRCC1 could not be
aﬀected by GSNO at all. A similar phenomenon was also
observed in COS-7 cells (data not shown). Thus, it is
suggested that GSNO selectively induced cytosolic trans-
location of APE1 but not all the nuclear proteins.
To determine whether the GSNO-induced nuclear exclu-
sion of APE1 was time or dose dependent, we stimulated
the cells with 1mM GSNO for diﬀerent time.
As Figure 1C shows, consistent with the endogenous
APE1 in HepG2 cells, transfected APE1 time-dependently
translocated into the cytosol in response to GSNO
stimulation. About 60% of transfected APE1 was
completely expelled to the cytoplasm within 4h. It was
also observed that GSNO induced nuclear export of APE1
in a dose-dependent manner. Treatment with up to 1mM
GSNO exerted the most signiﬁcant eﬀect on APE1
translocation (Figure 1D). To know whether
GSNO-induced intracellular redistribution of APE1 was
attributed to the synthesis of new proteins, CHX,
a protein synthesis inhibitor, was used. It turned out
that CHX could not prevent GSNO-induced APE1
nuclear export (Figure 2A).
Most proteins that undergo nucleocytoplasmic
traﬃcking depend on the nuclear export receptor CRM1
for nuclear export. It was speculated in a recent report
that APE1 probably bore a CRM1-dependent nuclear
export sequence (NES) (21). To test whether
GSNO-induced nuclear export of APE1 was associated
with the CRM1 pathway, HEK293 cells transfected
with HA-APE1 were pre-incubated with LMB,
a CRM1-speciﬁc inhibitor, and then stimulated with
GSNO. Figure 2B showed that LMB failed to prevent
GSNO-induced nuclear export of APE1. As a parallel
control, LMB treatment markedly induced nuclear
accumulation of transfected GFP-IkB (Figure 2C),
whose nuclear export is dependent on CRM1 pathway
(34,43). Therefore, this result indicated that the nuclear
export of APE1 induced by GSNO may be not via a
classical CRM1-dependent pathway.
S-nitrosation of APE1atcysteines 93 and 310 controlled
its nuclear-cytosolic shuttling
S-nitrosation, as a post-translational modiﬁcation, has
been implicated in nitric-oxide-elicited multiple cellular
eﬀects (26,27). To investigate the possibility that
GSNO-induced nuclear export of APE1 is regulated by
nitrosation modiﬁcation, we ﬁrst examined whether
transfected HA-APE1 could be S-nitrosated using the
biotin-switch assay, in which all the S-nitrosated cysteines
can be speciﬁcally identiﬁed on Western blots after
replacing -SNO with a more stable biotin group by
chemical reduction with ascorbate, as described previously
(30,42). As shown in Figure 3A, treatment of HEK293
cells with 1mM GSNO for 4h signiﬁcantly induced
HA-APE1 S-nitrosation. In contrast, H2O2 treatment
did not induce such modiﬁcation (data not shown),
indicating the speciﬁcity of this method. To further
conﬁrm this modiﬁcation, the cells were stimulated with
GSNO for 4h, followed by DTT or NAC for another 2h.
As shown in Figure 3A, the S-nitrosated form of APE1
was totally eliminated. Since both DTT and NAC have
2524 Nucleic Acids Research, 2007, Vol. 35, No. 8Figure 1. GSNO stimulated the translocation of APE1 from nucleus to cytoplasm. (A) GSNO induced nuclear-cytosolic translocation of endogenous
APE1 in HepG2 cells. Cells were stimulated with 1mM GSNO for indicated time. Cytoplasmic and nuclear fractions were separated by SDS/PAGE
and analyzed by immunoblotting with antibody against APE1. Antibodies against tubulin and histone H1 were used to ensure equal cytosolic and
nuclear loading, respectively. A representative of three independent experiments with similar results is shown. (B) Representative ﬂuorescence images
of ﬁxed HEK293 cells co-transfected with HA-tagged APE1 and GFP-XRCC1 in the presence or absence of 1mM GSNO for 4h treatment.
HA-APE1 was detected with the anti-HA primary antibody and a Texas-Red-labeled second antibody. XRCC1 was visualized by GFP. The nuclei
were stained with Hoechst 33342. The merged image was also shown. (C) Time-dependent translocation of HA-APE1 overexpressed in HEK293 cells
in response to GSNO determined by immunoﬂuorescence with anti-HA. Cells were stimulated with 1mM GSNO for 0.5, 1, and 4h, and the
distribution patterns of HA-APE1 were scored for at least 100 cells and classiﬁed into three categories: C, cytoplasmic-dominant distribution; NþC,
roughly equal distribution in nuclear and cytoplasmic compartments; and N, nuclear-dominant distribution. (D) Dose-dependent eﬀect of GSNO on
the nuclear export of HA-APE1. Cells were stimulated with GSNO at the indicated concentrations for 4h.
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these observations suggested that S-nitrosation of APE1
was a reversible process. Furthermore, we did observe that
the endogenous APE1 could be eﬀectively S-nitrosated in
multiple cell types including HepG2, Eahy926, SH-SY5Y
and RAW264.7 cells (unpublished data).
In the next series of experiments, we sought to identify
the speciﬁc sites of APE1 S-nitrosation. APE1 contains
seven cysteine amino acid residues, three of which,
including Cys65, Cys93 and Cys310, are redox-sensitive.
The Cys65 and Cys93 residues are located within the
redox-active domain, and Cys65 has been speculated to be
the redox-active site in the regulation of transcription
factor activity. The Cys310 residue resides in the
endonuclease domain, and its oxidative modiﬁcation has
been implicated in regulation of the DNA-repair
function (4). For this reason, we hypothesize that the
three redox-sensitive cysteines were the potential targets
of APE1 S-nitrosation. We ﬁrst developed three
single-point mutants APE1(C65S), APE1(C93S) and
APE1(C310S), and used the biotin-switch method to
test for their nitrosation. As demonstrated in Figure 3C,
D and E, mutation of a single residue of the three
cysteines to serine could not eliminate GSNO-induced
APE1 S-nitrosation in transfected HEK293 cells.
Consistently, PNRI-299, an APE1 Cys65 site blocker
(31), could not aﬀect APE1 nitrosation (Figure 3C). These
data suggested that there may be more than one
cysteine to be S-nitrosated. To test this hypothesis, we
simultaneously mutated the Cys93 and Cys310 to
serines. Interestingly, simultaneous mutation of Cys93
and Cys310 (the mutant was named ‘‘2CS’’) completely
prevented GSNO-induced APE1 nitrosation (Figure 3F),
although mutation of either one had no discernible eﬀect.
To further conﬁrm the result, we subsequently examined
whether mutation of all the three cysteines could
aﬀect the nitrosation of APE1. As expected, similar to
the APE1 (2CS), the triple mutant APE1 (3CS)
was refractory to NO-elicited nitrosation (Figure 3F).
Taken together, these results indicated that both
Cys93 and Cys310 of APE1 were S-nitrosated targets
in vivo.
To explore the possibility that S-nitrosation modiﬁca-
tion may determine the nuclear export of APE1, we
examined the eﬀects of DTT and NAC on GSNO-induced
APE1 nuclear-cytosolic translocation. As shown in
Figure 4A, both DTT and NAC could eﬀectively reverse
the GSNO-induced nuclear export of APE1, which was
consistent with their eﬀects on APE1 S-nitrosation,
suggesting that the nuclear export of APE1 may be an
S-nitrosation-dependent reversible process. To exclude the
possibility that GSNO-exerted regulatory eﬀect on APE1
translocation was attributed to the outcome of unspeciﬁc
oxidative stress, HEK293 cells expressing HA-APE1 were
exposed to 100mM or 1mM H2O2. As shown in
Figure 4A, H2O2 didn’t cause marked nuclear export of
APE1 as GSNO did (the data obtained with 100mMH 2O2
was not shown). This observation indicated that the
cytosolic translocation of APE1 was attributed to its
S-nitrosation rather than other oxidative modiﬁcations.
To ﬁnally establish the causal relationship of APE1
S-nitrosation and its nuclear export, we examined the
subcellular distributions of APE1 cysteine mutants in
the presence of GSNO. As shown in Figure 4B,
mutation of Cys65 did not prevent, but instead slightly
enhanced the GSNO-induced APE1 nuclear export.
Mutation of either Cys93 or Cys310 could partially
repress APE1 redistribution in response to GSNO
stimulation. However, signiﬁcantly, the S-nitrosation-
deﬁcient APE1 mutants, APE1 (2CS) and APE1 (3CS),
remained in the nucleus irrespective of the presence
of GSNO. Collectively, these observations clearly
indicate that S-nitrosation of APE1 determined its nuclear
export.
Figure 2. The eﬀects of CHX and LMB on GSNO-induced cytosolic
translocation of APE1. (A) Eﬀect of CHX. 30h after transfection, cells
were treated with 1mM GSNO for 4h in the presence or absence of
CHX, and then ﬁxed and immunostained by HA antibody and a Texas-
red labeled secondary antibody, counterstained with Hoechst 33342,
and analyzed by ﬂuorescence microscopy. (B) Eﬀect of LMB. HEK293
cells transfected with HA-APE1 were treated with 5ng/ml LMB for 4h,
followed by 1mM GSNO for another 4h, and then the subcellular
distribution of HA-APE1 was determined. (C) Positive control of
the eﬀect of LMB on the localization of GFP-IkB expressed in
HEK293 cells.
2526 Nucleic Acids Research, 2007, Vol. 35, No. 8Twobeta-strands inclose proximity to Cys93and Cys310
of APE1were important forNO-induced conditional
nuclear export
Except a ﬂexible N-terminal 35-residues portion, APE1
forms a tight globular structure (45,46). In order to
explain how NO-elicited nitrosation controlled nuclear
export of APE1, we hypothesized that APE1 may undergo
a conformational change upon S-nitrosation modiﬁcation,
which may lead to the exposure of a masked internal
region that facilitates its nuclear export. For this
consideration, we developed a series of N- and
C-terminal-truncated APE1 mutants (Figure 5B), which
were expected to unmask internal ‘NES’. All these
mutants were expressed in HEK293 cells as C-terminal
Myc fusion. Their proper expressions in HEK293 cells
were conﬁrmed by immunoblotting (supplementary
Figure 1A), and their subcellular localizations were
examined by immunoﬂuorescence with anti-Myc anti-
body. As Figure 5A shows, deletion of the N-terminal
43 residues of APE1, which contains the known NLS,
eﬀectively prevented APE1 from residing in the nucleus.
Further deletion of N-terminal 123 residues led to
complete nuclear exclusion of APE1. Interestingly, the
mutants with their N-terminal 180, 206 and 249 aa deleted
demonstrated a marked mitochondrial localization.
The immunoﬂuorescence images of these mutants were
overlapped with the co-transfected Mito-GFP, a mito-
chondrial indicator (data not shown). Although
Chattopadhyay et al. identiﬁed the mitochondrial-
localized APE1 as an N-terminal 33 residues-truncated
form (22,23), the MTS of APE1 has not been mapped yet.
Our work implied that the MTS is located in the
C-terminal 69 amino residues of APE1 (Figure 5A).
Interestingly, the MTS appears to be hidden by the
N-terminal sequence of APE1 and, therefore, inaccessible
to the protein surface, although the signiﬁcance of
the masked MTS is not known. Subsequently, to obtain
the more direct information about the putative NES,
the cellular localization of C-terminal-truncated mutants
were investigated. Consistent with the full-length APE1,
deletion of the C-terminal 13 aa did not alter the intra-
nuclear distribution of APE1 (Figure 5A). However,
surprisingly, further truncation up to N-terminal 122 aa
resulted in a signiﬁcant cytoplasmic distribution in
Figure 3. S-nitrosation of APE1at Cys93 and Cys310 in vivo.( A) S-nitrosation of HA-APE1 expressed in HEK293 cells in the presence of 1mM
GSNO as determined by biotin-switch assay. For certain experiment, GSNO-challenged cells were treated with 10mM DTT or 10mM NAC during
the last 2h of incubation. All the S-nitrosated proteins were precipitated and detected by Western blotting with anti-HA antibody.
(B) Schematic representation of APE1 and APE1 derivatives containing Cys-to-Ser mutations in various combinations. (C) GSNO-induced
S-nitrosation of APE1 (WT) and APE1(C65S) in the presence or absence of PNRI. (D–F) S-nitrosation of APE1(C93S), APE1(C310S), APE1(2CS)
and APE1(3CS).
Nucleic Acids Research, 2007, Vol. 35, No. 8 2527addition to its nuclear localization. Interestingly, the
cytosolic proportion of APE1 increased with the deletion
of more C-terminal aa residues. Notably, the mutant
APE1(1-80) containing N-terminal 80 aa residues showed
the least nuclear staining. However, once the region
containing the 64-80 aa residues was deleted, it was
relocalized in the nucleus (Figure 5A). Since the
N-terminal 20 amino acids portion of APE1 contains
NLS, these results indicated that the region (aa 64-80)
might serve as an ‘NES’ when it is suﬃciently unmasked.
Interestingly, treatment with LMB did not result in
nuclear accumulation of APE1(1-80) (data not shown),
suggesting that the ‘NES’ may function in a CRM1-
independent manner. In the next experiment, to evaluate
the importance of the sequence (aa 64-80) in nitric-oxide-
caused APE1 cytosolic translocation, we developed a
mutant APE1(64-80), in which the potential NES region
was deleted. Immunoﬂuorescence experiment showed
that this mutant completely lost the responsibility to
GSNO-induced nuclear export (Figure 5C). It should
be pointed out that the APE1(64-80) mutant could
slightly interfere with cell viability, while all of the other
APE1 mutants we used did not show any discernible
eﬀects (supplementary Figure 1B). In some sense, this
observation perhaps supported the functionality of
the aa.64-80 region.
Is there the possibility that S-nitrosation of APE1 leads
to the exposure of ‘‘NES’’? Analysis of APE1 ternary
structure revealed that the putative NES is composed of
a part of beta-strand (B1) and a part of alpha-helix
(H1) (45). Interestingly, Cys93 is adjacent to B1, whereas
Cys310 is linked to another B1-associated beta-strand
(aa 311-316, referred to B2). In structure, B1 and B2 form
an antiparellel beta-fold residing between Cys93 and
Cys310 (Figure 5D). To evaluate the importance of B2,
we examined the intracellular localization of APE1(1-305)
in the presence of GSNO. APE1(1-305) was chosen
because it included neither Cys310 nor B2. Figure 5C
showed that APE1(1-305) was rather insensitive to
GSNO-induced nuclear export. Considering that
APE1(C310S), the C310-inactive APE1 mutant, can still
translocate to the cytosol in response to GSNO
(Figure 4B), we concluded that B2 was another region
that may facilitate GSNO-induced export of APE1 from
nucleus. Thus, both the ‘NES’ and B2 beta-strand were
critical for NO-elicited APE1 cytosolic translocation,
Figure 4. S-nitrosation of APE1 determined its nuclear export.
(A) HA-APE1 subcellular distribution in transfected HEK293 cells
determined by immunoﬂuorescence after 4h-treatment with 1mM
GSNO, followed by co-treatment with 10mM DTT or 10mM NAC for
another 2h, and 1mM H2O2, respectively. (B) The subcellular
localizations of HA-APE1 or its various mutants were determined in
transfected HEK293 cells in the presence of 1mM GSNO.
Figure 5. Mapping of the APE1 domains responsible for GSNO-
induced nuclear export. (A) Immunoﬂuorescence images depicting the
subcellular localization of APE1 truncated mutants in transfected
HEK293 cells. (B) Schematic representation of the N-terminal and
C-terminal truncated mutants of APE1. The NLS and the predicted
NES and MTS within the full-length protein are indicated.
C, cytoplasmic staining; N, nuclear staining; M, mitochondrial staining.
(C) The subcellular distribution of HA-APE1(64-80) and
HA-APE1(1-305) determined by immunoﬂuorescence in the presence
of GSNO treatment. (D) Three-dimensional localization of the B1
(amino acids 61–69) and B2 (amino acids 311–317) beta-strands and the
S-nitrosation sites C93 and C310 in the closed conformation of APE1.
B1 and B2 form an antiparallel beta-fold. C93 and C310 are close to
B1 and B2, respectively.
2528 Nucleic Acids Research, 2007, Vol. 35, No. 8and the S-nitrosation of Cys93 and Cys310 may result
in a conformational change that facilitates the two
beta-strands to function.
Nitric-oxide-repressed classical importin-dependent nuclear
import pathway
The above experiments clearly indicated that S-nitrosation
determined the nuclear export of APE1. However, even if
APE1 could be eﬀectively exported into the cytosol by
GSNO, it is still likely to be reimported into the nucleus
via the classical nuclear import pathway. In fact, we did
observe a complete nuclear exclusion of APE1 in response
to GSNO stimulation. It has been reported that the
classical NLS nuclear import pathway could be impaired
by certain stresses such as UV irradiation, heat shock and
oxidative stress (47). To address the issue whether nitric
oxide was able to suppress the nuclear import of APE1,
the subcellular distribution of APE1(1-64), which contains
NLS but excludes most of its C-terminal portion, was
examined in the presence of GSNO. Immunoﬂuorescence
experiment revealed that APE1(1-64) was dominantly
localized in the nuclei of untreated cells (Figure 6A).
However, once cells were challenged with 1mM GSNO
for 4h, APE1(1-64) signiﬁcantly accumulated in the
cytoplasm (Figure 6A), suggesting that nitrosative stress
may disrupt the nuclear import function of this mutant
(Figure 2A). Since nuclear import of APE1 involves a
functional interaction between APE1 NLS and nuclear
import receptor importin (21), we next determined
whether the impaired nuclear import of APE1(1-64) was
due to the defect of importin transport system. Simian
virus 40 NLS is an established substrate for the importin
receptor; fusion of this NLS to double GFPs could target
the latter into the nucleus via importin (36). For this
reason, we examined whether the nuclear import of
SV40(NLS)-GFP-GFP could be repressed by nitric
oxide. As shown in Figure 6B, SV40(NLS)-GFP-GFP
was predominantly localized in the nucleus after 40h
transfection. However, when the cells were stimulated with
1mM GSNO for 4h, a markedly enhanced cytosolic
ﬂuorescence was observed. By comparison, GSNO treat-
ment could hardly aﬀect the nuclear localization of
M9-GFP-GFP (Figure 6B), whose nuclear import is
independent of the importin pathway (36). Thus, these
observations indicated that the nuclear import eﬃciency
of the classical NLS substrates was substantially decreased
in the NO-insulted cells.
To exclude the possibility that the defect of importin
nuclear import pathway could be totally responsible for
GSNO-induced cytosolic translocation of APE1,
APE1(43-318), which excludes NLS region but contains
the intact APE1 globular structure, was employed.
Indirect immunoﬂuorescence showed a diﬀuse whole-cell
distribution for this mutant, with a predominantly
cytosolic staining (Figure 6C), indicating that a small
proportion of APE1 molecules could diﬀuse into the
nucleus in an NLS-independent manner. Surprisingly, the
intra-nuclear APE1(43-318) could be totally exported into
cytoplasm in the presence of GSNO (Figure 6C). This
result, together with previous observations that the NLS-
containing APE1 mutants (2CS, 3CS, 1-305, and 64-80)
were refractory to GSNO-induced cytosolic translocation
(Figure 4B, 5A), and the fact that H2O2, a functional
importin inhibitor (47), cannot promote nuclear export of
APE1 (Figure 4A), strongly indicated that repression
of nuclear import of APE1 was not suﬃcient for
GSNO-induced nuclear export of APE1. Its contribution
may lie in preventing cytosolic APE1 from retransporting
into the nucleus.
HDAC2and p50 antagonized GSNO-induced
nuclearexport ofAPE1
The above studies on the APE1 translocation were mainly
based on APE1-overexpressed cell systems, in which the
expression level of APE1 should be much higher than
those of other proteins in cells. Therefore, it is necessary to
investigate whether certain proteins could interfere with
GSNO-induced APE1 nuclear export at physiologically
comparable expression levels. For this consideration, the
GSNO-induced APE1 nuclear export was reexamined by
cotransfection of HA-APE1 with several established
APE1-binding proteins, respectively. It was shown in
Figure 7 that, among the tested APE1-binding proteins,
only p50 (48) and HDAC2 (13), when overexpressed,
respectively, could partially prevent GSNO-induced APE1
nuclear export. Other proteins including p53 (49),
thioredoxin (Trx) (3) and XRCC1 (50) had little eﬀect.
Figure 6. Nitric-oxide-repressed classical importin-mediated nuclear
import pathway. (A) Left: Schematic presentation of the
NLS-containing APE1(1-64) mutant. Right: Immunoﬂuorescence
images depicting the localization of APE1(1-64)-Myc in HEK293 cells
challenged with or without 1mM GSNO for 4h. (B) Confocal images
depicting the localization of (GFP)2-NLS and (GFP)2-M9 in HEK293
cells treated with GSNO for 4h. (C) Left: Schematic presentation of the
NLS-truncated mutant APE1(43-318)-Myc Right: Immunoﬂuorescence
images depicting the localization of APE1(43-318)-Myc in HEK293
cells challenged with or without 1mM GSNO for 4h.
Nucleic Acids Research, 2007, Vol. 35, No. 8 2529These data suggested that the nitric-oxide-regulated APE1
nuclear export may be a complicated and cellular-context-
dependent process.
DISCUSSION
Post-translational protein modiﬁcation is a crucial
mechanism to regulate protein function in eukaryotic
cells. Similar to other post-translational modiﬁcations,
protein S-nitrosation exerts pleiotropic eﬀects on its target
proteins, ranging from altered protein stabilization to
changed activity or function (26). Recently, Hara et al.
reported that S-nitrosation mediated nuclear translocation
of GAPDH. In the current investigation, we revealed that
S-nitrosation mediated nuclear export of APE1. To our
knowledge, this is the ﬁrst evidence that S-nitrosation
modiﬁcation is able to control protein nuclear export,
although other post-translational modiﬁcations, includ-
ing phosphorylation (51), ubiquitination (52), sumoyla-
tion (53), acetylation (54), and thiol modiﬁcation (55) have
already been involved in such processes. For APE1, to
date, the potential phosphorylation sites, acetylation sites,
and granzyme A-cleavage sites have been well established,
and the modiﬁcation of these sites have been known to
change APE1 activity (12,13,56). However, the potential
S-nitrosation sites of APE1 and the eﬀect of this
modiﬁcation on APE1 have not been reported. Our
ﬁnding also provided the ﬁrst evidence that nitrosative
stress regulated APE1 by subcellular translocation
through S-nitrosation mechanism.
Strikingly, this inducible cytosolic translocation of
APE1 is an NO-related phenomenon. Firstly, the nuclear
export of APE1 was not sensitive to other oxidative
stresses such as H2O2 (Figure 4A), which may cause
a higher oxidative form of APE1, although the possibility
has not been excluded that H2O2 may act in a similar
manner as NO in the regulation of APE1 traﬃck-
ing in other unexamined cell types. In addition,
GSNO selectively induced cytosolic translocation of
APE1, but not other DNA-repair-related proteins such
as XRCC1 (Figure 1B) and thymine DNA glycosylase
(data not shown). It should be pointed out that, although
the APE1 nuclear export is speciﬁc to NO, the
endogenous APE1 appears to show diﬀerent sensitivities
to NO-induced nuclear export among diﬀerent cell types.
Of note, the endogenous APE1 in human endothelial cells
is strongly refractory to NO-induced nuclear export,
although it can still be eﬀectively S-nitrosated under the
same circumstances (unpublished data).
Although the precise mechanism by which S-nitrosation
controls nuclear export of APE1 is not clear, two anti-
parallel beta-strands close to Cys93 and Cys310 were
found to be critical for the nitrosation-mediated cytosolic
translocation of APE1. Previous study revealed that
phosphorylation of MK2 can result in intra-molecular
de-masking of an NES and, therefore, mediate its nuclear
export (51). Therefore, the conformational change
and ‘NES’ exposure of APE1 caused by S-nitrosation
modiﬁcation can be expected in this study. We demon-
strated that one of the beta-strands (B1) was functional,
as the exposure of B1-containing sequence through
C-terminal truncation could mediate protein cytosolic
localization even in the presence of N-terminal NLS
(Figure 5A). The direct evidence about whether the
C-terminal B2 strand is another NO-responsive ‘‘NES’’
has not been proved. However, either deletion of B2
(Figure 5C) or fusion of GFP to APE1at the B2 end
(unpublished data) strongly repressed NO-stimulated
nuclear export, suggesting that a proper conformational
change of B2 may contribute to the NO-induced cytosolic
translocation of APE1. B1 and B2 may cooperate with
each other in mediating APE1 nuclear export. Alternately,
they functioned independently, providing that the inter-
strand interaction was disrupted as a result of APE1
S-nitrosation (Figure 8). In addition, it should be
emphasized that the nuclear export eﬃciency of APE1
was high, as a 4-h GSNO treatment almost led to a
complete nuclear exclusion of APE1. This phenomenon
may be attributed to NO-caused impaired nuclear import
of APE1 that helped in preventing the already exported
APE1 from reimporting into nucleus. Diﬀerent from the
APE1-overexpressed cell system, the nuclear-cytosolic
shuttling of APE1 may be interfered by some of its
binding proteins at normal physiological conditions. It is
possible that the protein–protein interactions can repress
export of APE1 from nucleus to cytosol. HDAC2 and p50
proteins may act as such intra-nuclear gatekeepers for
their ability to antagonize NO-induced APE1 traﬃcking
(Figure 7). The diﬀerential intra-nuclear levels of APE1-
binding proteins may partly contribute to the cell-type-
speciﬁc phenomena in APE1 nuclear export. Therefore,
the NO-caused APE1 cytosolic translocation may be a
complicated process, simultaneously involved in
S-nitrosation of Cys93 and Cys310 leading to ‘‘NES’’
exposure, interaction of APE1 with other nuclear proteins
and defect in importin nuclear import pathway.
In summary, we have reported here that nitric oxide
controlled the nuclear export of APE1 through
S-nitrosation of Cysteines 93 and 310, which described a
Figure 7. Proteins interfering with NO-induced APE1 nuclear export.
HEK293 cells were cotransfected with HA-APE1 together with the
expression vector encoding HDAC2, p50, p53, Trx, XRCC1, respec-
tively, for 40h, and then stimulated with 1mM GSNO for 4h. The
subcellular distribution of HA-APE1 was determined by
immunoﬂuorescence.
2530 Nucleic Acids Research, 2007, Vol. 35, No. 8novel link between the nitrosative stress and DNA repair/
transcriptional regulation system. It has been reported
that redox modiﬁcation of Cys310 of APE1 can repress its
AP endonuclease activity (14). Thus, it is reasonable to
expect that NO may exert inﬂuence on APE1 DNA repair
function through nitrosation of this site. Unraveling the
detailed mechanism by which S-nitrosation of APE1
controlled its nuclear export (such as whether a vehicle
protein is required for the translocation) and revealing
whether S-nitrosation of APE1 can aﬀect its other
biological functions present an exciting and relevant
challenge for future research. Since NO and APE1 are
connected to tumorigenesis and neurodegenerative dis-
eases, the present ﬁndings will reasonably improve our
understanding of how nitrosative stress leads to DNA
damaging at the DNA-repair level and have the potential
to yield therapeutic strategies to ﬁght these diseases.
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